New Evidence to Support Antibiotic Prophylaxis in Meconium-Stained Amniotic Fluid in Low-Risk Women in Labor a Prospective Cohort Study
- PMID: 30224839
- PMCID: PMC6133797
- DOI: 10.1007/s13224-017-1043-y
New Evidence to Support Antibiotic Prophylaxis in Meconium-Stained Amniotic Fluid in Low-Risk Women in Labor a Prospective Cohort Study
Abstract
Purpose of study: To assess the maternal and perinatal complications associated with meconium-stained amniotic fluid (MSAF) in low-risk women in labor.
Methods: This prospective cohort study was conducted at CMC Hospital, Vellore, India. Two hundred low-risk women who had artificial or spontaneous rupture of membranes after admission with MSAF were included in the study. Two hundred similar women with clear liquor were taken as controls. The primary outcomes considered were the incidence of chorioamnionitis and endomyometritis in the mothers. The secondary outcomes included postpartum hemorrhage and retained placenta in the mothers and respiratory distress, meconium aspiration, sepsis, and NICU admission in the newborn. Statistical analysis was done using Fischer exact test. Odds ratio, 95% confidence interval, and P value were estimated.
Results: Compared to controls, those with MSAF had significantly higher rates of chorioamnionitis (2 vs. 8%, P = 0.006) and endomyometritis (3 vs. 9.5% P = 0.007). Among the secondary end points, only neonatal respiratory distress (8.5 vs. 1.5%; P = 0.001) and meconium aspiration (4 vs. 0%; P = 0.007) were found to be significantly increased in the meconium group.
Conclusion: Statistically significant increased incidence of chorioamnionitis and endomyometritis in women with MSAF in labor established in our study strongly supports the use of prophylactic antibiotics in these women to prevent immediate and long-term consequences.
Keywords: Chorioamnionitis; Endomyometritis; Meconium aspiration syndrome; Meconium-stained liquor; Neonatal sepsis; Respiratory distress syndrome.
Conflict of interest statement
All authors declare that they have no conflict of interest.All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the 1975 Declaration of Helsinki, as revised in 2008 (5).Informed consent was obtained from all patients for being included in the study.
References
-
- James D, Steer P, Weiner CP. High risk pregnancy management options. 4. Amsterdam: Elsevier; 2011. pp. 1135–1140.
-
- Brabbing-Goldstein D, Nir D, Cohen D, et al. Preterm meconium-stained amniotic fluid is an ominous sign for the development of chorioamnionitis and for in utero cord compression. J Matern Fetal Neonatal Med. 2017;8:1–4. - PubMed
-
- Hiersch L, Krispin E, Aviram A, et al. Effect of meconium stained amniotic fluid on low risk pregnancies at term. Am J Perinatol. 2016;33(4):378–384. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials